- $10.73bn
- $10.42bn
- $738.26m
Repligen Corporation reports results for the quarter ended September 30 - Earnings Summary
Repligen Q3 revenue beats estimates on higher demand; lifts outlook
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Repligen Corp reports results for the quarter ended June 30 - Earnings Summary
Repligen Q2 revenue beats estimates on higher orders; raises outlook
Brief: Biolife Solutions Co May Be Required To Pay Repligen Termination Fee Of $59 Million, If Deal Terminates Under Certain Circumstances- SEC Filing
Deals of the day-Mergers and acquisitions
BioLife climbs after agreeing to be bought by Repligen in $1.5 billion deal
Deals of the day-Mergers and acquisitions
Brief: Repligen To Acquire Biolife Solutions, Expanding Its Cell Therapy Capabilities With Market Leading Biopreservation Media
BioLife Solutions climbs on $1.5 billion Repligen buyout
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife (updated)
Repligen to buy BioLife Solutions in $1.5 billion deal
U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
Brief: Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom
Repligen Q1 revenue rises 15%, adjusted EPS beats estimates
U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP
Repligen Q4 revenue beats estimates on Analytics and Proteins growth